| Filed On | Filing |
|---|---|
| 13 Oct 2026 |
8-K/A: Financial Statements and Exhibits
The following unaudited pro forma condensed combined financial information combines the historical financial position and results of operations of Tarsus Pharmaceuticals, Inc., a Delaware corporation (“Tarsus”), and Alkeus Pharmaceutical... |
Loading...
